Abstract
Macrophages have various functions and play a critical role in host defense and the maintenance of homeostasis. However, macrophages are heterogeneous and exhibit a wide range of phenotypes with regard to their morphology, cell surface antigen expression, and function. When blood monocytes are cultured in medium alone in vitro, monocytes die, and colony-stimulating factors (CSFs) such as macrophage (M)-CSF or granulocyte-macrophage (GM)-CSF are necessary for their survival and differentiation into macrophages. However, M-CSF-induced monocyte-derived macrophages (M-MΦ) and GM-CSF-induced monocyte-derived macrophages (GM-MΦ) are distinct in their morphology, cell surface antigen expression, and functions, including Fcγ receptor mediated-phagocytosis, H2O2 production, H2O2 sensitivity, catalase activity, susceptibility to human immunodeficiency virus type 1 andMycobacterium tuberculosis, and suppressor activity. The characteristics of GM-MΦ resemble those of human alveolar macrophages.
Similar content being viewed by others
References
Kennedy DW, Abkowitz JL. Mature monocytic cells enter tissues and engraft.Proc Natl Acad Sci U S A. 1998;95:14944–14949.
Hume DA, Robinson AP, MacPherson GG, Gordon S. The mononuclear phagocyte system of the mouse defined by immuno- histochemical localization of antigen F4/80: relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs.J Exp Med. 1983;158: 1522–1536.
Burdach S, Nishinakamura R, Dirksen U, et al. The physiologic role of interleukin-3, interleukin-5, granulocyte-macrophage colony- stimulating factor, and the beta c receptor system.Curr Opin Hematol. 1998;5:177–180.
Motoyoshi K. Biological activities and clinical application of M-CSF.Int J Hematol. 1998;67:109–122.
Motoyoshi, K. Macrophage colony-stimulating factor.Nippon Rinsho. 1999;57(suppl):765–768.
Akagawa KS, Kamoshita K, Tokunaga T. Effects of granulocyte- macrophage colony-stimulating factor and colony-stimulating fac- tor-1 on the proliferation and differentiation of murine alveolar macrophages.J Immunol. 1988;141:3383–3390.
Burgess W, Camakaris J, Metcalf D, et al. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.J Biol Chem. 1997;252:1998–2003.
Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granu- locyte-macrophage colony-stimulating factor in pulmonary home- ostasis.Science. 1994;264:713–716.
Robb L, Drinkwater CC, Metcalf.D, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.Proc Natl Acad Sci U S A. 1995;92:9565–9569.
Zsengeller ZK, Reed JA, Bachurski CJ, et al. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte- macrophage colony-stimulating factor-deficient mice.Hum Gene Ther. 1998;9:2101–2109.
Naito M, Umeda S, Takahashi K, et al. Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1.Mol Reprod Dev. 1997: 46:85–91.
Akagawa KS,Takasuka N, Nozaki Y, et al. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes.Blood. 1996;88:4029–4039.
Akagawa K. Differentiation and function of human monocytes.Hum Cell. 1994;7:116–120.
Akagawa KS. Generation of two phenotypically distinct types of macrophages, CD1+ dendritic cells, TRAP+ osteoclast-like multinucleated giant cells from human monocytes.Jpn J Med Mycol. 1997;38:209–214.
Koyama Y,Yamanoha B, Yoshida T, et al. A novel monoclonal antibody induces the differentiation of monocyte leukemic cells.Biochem Biophys Res Commun. 1990;168:898–904.
Young DA, Lowe LD, Clark SC. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture: analysis of macrophage antibody-dependent cellular cytotoxicity.J Immunol. 1990;145:607–615.
De Nichilo MO, Burns GF, Koyama Y, et al. Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages.Proc Natl Acad Sci U S A. 1993;90:2517–2521.
Nakata K,Akagawa KS, Fukayama M, et al. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro.J Immunol. 1991;147:1266–1272.
Radzun HJ, Kreipe H, Heidorn K, Parwaresch MR. Modulation of c-fms proto-oncogene expression in human blood monocytes and macrophages.J Leukoc Biol. 1988;44:198–204.
Andreesen R, Brugger W, Scheibenbogen.C, et al. Surface phenotype analysis of human monocyte to macrophage maturation.J Leukoc Biol. 1990;47:490–497.
Krombach F, Gerlach JT, Padovan.C, et al. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease.Eur Respir J. 1996;9:984–991.
Crowley MT, Costello PS, Fitzer-Attas.CJ, et al. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages.J Exp Med. 1997;186:1027–1039.
Kiefer F, Brumell J, Al-Alawi N, et al. The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils.Mol Cell Biol. 1998;18:4209–4220.
Fitzer-Attas, CJ, Lowry M, Crowley MT, et al. Fcgamma receptor- mediated phagocytosis in macrophages lacking the Src family tyro- sine kinases Hck, Fgr, and Lyn.J Exp Med. 2000;191:669–682.
Ravetch JV, Bolland S. IgG Fc receptors.Annu Rev Immunol. 2001: 19:275–290.
Brooks D, Ravetch JV. Fc receptor signaling.Adv Exp Med Biol. 1994;365:185–195.
Komuro I, Keicho N, Iwamoto A, Akagawa KS. Human alveolar macrophages and granulocyte-macrophage colony-stimulating factor -induced monocyte-derived macrophages are resistant to H2O2 via their high basal and inducible levels of catalase activity.J Biol Chem. 2001;276:24360–24364.
Desai G, Nassar F, Brummer E, Stevens DA. Killing of Histoplasma capsulatum by macrophage colony stimulating factortreated human monocyte-derived macrophages: role for reactive oxygen intermediates.J Med Microbiol. 1995;43:224–229.
Nassar F, Brummer E, Stevens DA. Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing.Cell Immunol. 1995;164:113–118.
Danel C, Erzuru SC, Prayssac.P, et al. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury.Hum Gene Ther. 1998;9:1487–1496.
Nakata K, Gotoh H, Watanabe J, et al. Augmented proliferation of human alveolar macrophages after allogeneic bone marrow transplantation.Blood. 1999;93:667–673.
Forman HJ, Torres M. Redox signaling in macrophages.Mol Aspects Med. 2001;22:189–216.
Ghorpade A, Xia MQ, Hyman BT, et al. Role of the betachemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia.J Virol. 1998;72:3351–3361.
Lane BR, Markovitz DM, Woodford NL, et al. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.J Immunol. 1999;163:3653–3661.
Crowe SM, Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication.J Leukoc Biol. 2000;68:345–350.
Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature. 1997;387:183–188.
Li S, Juarez J, Alali M, et al. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates.J Virol. 1999;73: 9741–9755.
Matsuda S, Akagawa K, Honda M, et al. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor.AIDS Res Hum Retroviruses. 1995;11:1031–1038.
Berkowitz RD, Alexander S, Bare C, et al. CCR5- and CXCR4- utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo.J Virol. 1998;72: 10108–10117.
Lee B, Sharron M, Montaner LJ, et al. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.Proc Natl Acad Sci U S A. 1999;96:5215–5220.
Worgall S, Connor R, Kaner RJ, et al. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.J Virol. 1999;73:5865–5874.
Henderson AJ, Calame KL. CCAAT/enhancer binding protein (C/ EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.Proc Natl Acad Sci U S A. 1997;94: 8714–8719.
Baer M, Williams SC, Dillner A, et al. Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages.Blood. 1998;92:4353–4365.
Xiong W, Hsieh CC, Kurtz AJ, et al. Regulation of CCAAT/ enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites.Nucleic Acids Res. 2001;29:3087–3098.
Honda Y, Rogers L, Nakata K, et al. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.J Exp Med. 1998;188:1255–1265.
Weiden M,Tanaka N, Qiao Y, et al. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression.J Immunol. 2000;165:2028–2039.
Moarefi I, LaFevre-Bernt M, Sicheri F, et al. Activation of the Srcfamily tyrosine kinase Hck by SH3 domain displacement.Nature. 1997;385:650–653.
Swingler S, Mann A, Jacque J, et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.Nat Med. 1999;5:997–1103.
Kurata S, Yamamoto N. Glucocorticoid can reduce the transcrip- tional activation of HIV-1 promoter through the reduction of active NF-kappaB.J Cell Biochem. 1999:76:13–19.
Klebanoff SJ, Headley CM. Activation of the human immunodeficiency virus-1 long terminal repeat by respiratory burst oxidants of neutrophils.Blood. 1999;93:350–356.
Nakata K, Weiden M, Harkin T, Ho D, Rom WN. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations.Mol Med. 1995;1:744–757.
Russell DG. Mycobacterium tuberculosis: here today, and here tomorrow.Nat Rev Mol Cell Biol. 2001;2:569–577.
Deretic V, Fratti R. A. Mycobacterium tuberculosis phagosome.Mol Microbiol. 1999;31:1603–1609.
MacMicking JD, North RJ, LaCourse R, et al. Identification of nitric oxide synthase as a protective locus against tuberculosis.Proc Natl Acad Sci U S A. 1997;94:5243–5248.
Hanano R, Kaufmann SH. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation.Immunol Lett. 1995;45:23–27.
Rook GA, Taverne J, Leveton C, Steele, J. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.Immunology. 1987;62:229–234.
Akagawa KS, Komuro I, Yamazaki T, Haga S. Mechanisms of antibacterial activity of human macrophages against Mycobacterium tuberculosis. In: Proceedings of Thirty-sixth US-Japan Tuberculosis and Leprosy Research Conference; July 16, 2001; New Orleans, La.
Gao PS, Fujishima S, Mao XQ, et al. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team.Clin Genet. 2000;58:74–76.
Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV.Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.N Engl J Med. 1998;338:640–644.
Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors.Science. 2001;291:1544–1547.
Mochida-Nishimura K,Akagawa KS, Rich EA. Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocytemacrophage colony-stimulating factor.Cell Immunol. 2001;214: 81–88.
Upham JW, Strickland DH, Robinson BW, Holt PG. Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages.Thorax. 1997;52:786–795.
Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima, K. Serial analysis of gene expression in human monocytes and macrophages.Blood. 1999;94:837–844.
Shibata Y, Berclaz PY, Chroneos ZC, et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.Immunity. 2001;15:557–567.
Miyamoto T, Ohneda O, Arai F, et al. Bifurcation of osteoclasts and dendritic cells from common progenitors.Blood. 2001;98: 2544–2554.
Hashimoto S, Yamada M, Motoyoshi K, Akagawa KS. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10.Blood. 1997;89:315–321.
Hashimoto S, Komuro I, Yamada, M, Akagawa KS. Il-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages.J Immunol. 2001;167: 3619–3625.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Akagawa, K.S. Functional Heterogeneity of Colony-Stimulating Factor-Induced Human Nonocyte-Derived Macrophages. Int J Hematol 76, 27–34 (2002). https://doi.org/10.1007/BF02982715
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982715